Engelstalige publicaties Slotervaartziekenhuis 2009 

     (1)   Aarab, G.; Lobbezoo, F.; Hamburger, H. L.; Naeije, M. Variability in the Apnea-Hypopnea Index and Its Consequences for Diagnosis and Therapy Evaluation. Respiration 2009, 77, 32-37.

     (2)   Amant, F.; Van Calsteren, K.; Halaska, M. J.; Beijnen, J.; Lagae, L.; Hanssens, M.; Heyns, L.; Lannoo, L.; Ottevanger, N. P.; Bogaert, W. V.; Ungar, L.; Vergote, I.; Du Bois, A. Gynecologic Cancers in Pregnancy: Guidelines of an International Consensus Meeting. Int. J. Gynecol. Cancer 2009, 19.

     (3)   Bakker, J. J.; De Vos, R.; Pel, M.; Wisman, C.; Van Lith, J. M.; Mol, B. W. J.; Van Der Post, J. A. Start of Induction of Labour With Oxytocin in the Morning or in the Evening. A Randomised Controlled Trial. BJOG Int. J. Obstet. Gynaecol. 2009, 116, 562-568.

     (4)   Beumer, J. H.; Franke, N. E.; Tolboom, R.; Buckle, T.; Rosing, H.; Lopez-Lazaro, L.; Schellens, J. H.; Beijnen, J. H.; van Tellingen, O. Disposition and Toxicity of Trabectedin (ET-743) in Wild-Type and Mdr1 Gene (P-Gp) Knock-Out Mice. Invest New Drugs 2009.

     (5)   Beumer, J. H.; Lopez-Lazaro, L.; Schellens, J. H.; Beijnen, J. H.; van Tellingen, O. Evaluation of Human Plasma Protein Binding of Trabectedin (Yondelis, ET-743). Curr. Clin. Pharmacol. 2009, 4, 38-42.

     (6)   Bomers, M. K.; Lettinga, K. D.; van Gorp, E. C.; Martina, B. E.; Peerbooms, P. G.; Veenstra, J. [Dengue Infection With Fatal Ending]. Ned. Tijdschr. Geneeskd. 2009,  153, A725.

     (7)   Boss, D. S.; Siegel-Lakhai, W. S.; Egmond-Schoemaker, N. E.; Pluim, D.; Rosing, H.; Bokkel Huinink, W. W.; Beijnen, J. H.; Schellens, J. H. Phase I Pharmacokinetic and Pharmacodynamic Study of Carboplatin and Topotecan Administered Intravenously Every 28 Days to Patients With Malignant Solid Tumors. Clin. Cancer Res. 2009,  15, 4475-4483.

     (8)   Boss, D. S.; Beijnen, J. H.; Schellens, J. H. M. Clinical Experience With Aurora Kinase Inhibitors: A Review. Oncologist 2009, 14, 780-793.

     (9)   Brandsma, D.; van den Bent, M. J. Pseudoprogression and Pseudoresponse in the Treatment of Gliomas. Curr. Opin. Neurol. 2009.

   (10)   Brouwers, E. E.; Sohne, M.; Kuipers, S.; van Gorp, E. C.; Schellens, J. H.; Koks, C. H.; Beijnen, J. H.; Huitema, A. D. Ciprofloxacin Strongly Inhibits Clozapine Metabolism : Two Case Reports. Clin. Drug Investig. 2009, 29, 59-63.

   (11)   Brouwers, E. E.; Huitema, A. D.; Boogerd, W.; Beijnen, J. H.; Schellens, J. H. Persistent Neuropathy After Treatment With Cisplatin and Oxaliplatin. Acta Oncol. 2009, 48, 832-841.

   (12)   Cavaletti, G.; Cornblath, D. R.; Postma, T. J.; Merkies, I. S.; Argyriou, A.; Boogerd, W.; Briani, C.; Bruna, J.; Faber, C. G.; Grisold, W.; Heimans, J. J.; Kalofonos, H.; Krarup-Hansen, A.; Koeppen, S.; Lauria, G.; Leandri, M.; Mielke, S.; Nobile-Orazio, E.; Pace, A.; Padua, L.; Plasmati, R.; Psimaras, D.; Ros, T.; Schenone, A.; Stragliotto, G.; Galimberti, S.; Valsecchi, M. G. CI-PERINOMS: Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Study. J Peripher. Nerv. Syst. 2009, 14, 69-71.

   (13)   Comezoglu, S. N.; Ly, V. T.; Zhang, D.; Humphreys, W. G.; Bonacorsi, S. J.; Everett, D. W.; Cohen, M. B.; Gan, J.; Beumer, J. H.; Beijnen, J. H.; Schellens, H. M.; Lappin, G. Biotransformation Profiling of [(14)C]Ixabepilone in Human Plasma, Urine and Feces Samples Using Accelerator Mass Spectrometry (AMS). Drug Metab Pharmacokinet.  2009, 24, 511-522.

   (14)   Damen, C. W.; Chen, W.; Chakraborty, A. B.; van Oosterhout, M.; Mazzeo, J. R.; Gebler, J. C.; Schellens, J. H.; Rosing, H.; Beijnen, J. H. Electrospray Ionization Quadrupole Ion-Mobility Time-of-Flight Mass Spectrometry As a Tool to Distinguish the Lot-to-Lot Heterogeneity in N-Glycosylation Profile of the Therapeutic Monoclonal Antibody Trastuzumab. J. Am. Soc. Mass Spectrom. 2009, 20, 2021-2033.

   (15)   Damen, C. W.; Schellens, J. H.; Beijnen, J. H. Bioanalytical Methods for the Quantification of Therapeutic Monoclonal Antibodies and Their Application in Clinical Pharmacokinetic Studies. Hum. Antibodies 2009, 18, 47-73.

   (16)   Damen, C. W.; Speijer, H.; Hermens, W. T.; Schellens, J. H.; Rosing, H.; Beijnen, J. H. The Bioanalysis of Trastuzumab in Human Serum Using Precipitate-Enhanced Ellipsometry. Anal. Biochem.  2009, 393, 73-79.

   (17)   Damen, C. W.; Lagas, J. S.; Rosing, H.; Schellens, J. H.; Beijnen, J. H. The Bioanalysis of Vinorelbine and 4-O-Deacetylvinorelbine in Human and Mouse Plasma Using High-Performance Liquid Chromatography Coupled With Heated Electrospray Ionization Tandem Mass-Spectrometry. Biomed. Chromatogr. 2009, 23, 1316-1325.

   (18)   Damen, C. W.; Derissen, E. J.; Schellens, J. H.; Rosing, H.; Beijnen, J. H. The Bioanalysis of the Monoclonal Antibody Trastuzumab by High-Performance Liquid Chromatography With Fluorescence Detection After Immuno-Affinity Purification From Human Serum. J. Pharm. Biomed. Anal. 2009, 50, 861-866.

   (19)   Damen, C. W.; de Groot, E. R.; Heij, M.; Boss, D. S.; Schellens, J. H.; Rosing, H.; Beijnen, J. H.; Aarden, L. A. Development and Validation of an Enzyme-Linked Immunosorbent Assay for the Quantification of Trastuzumab in Human Serum and Plasma. Anal. Biochem. 2009, 391, 114-120.

   (20)   Damen, C. W.; Rosing, H.; Schellens, J. H.; Beijnen, J. H. Application of Dried Blood Spots Combined With High-Performance Liquid Chromatography Coupled With Electrospray Ionisation Tandem Mass Spectrometry for Simultaneous Quantification of Vincristine and Actinomycin-D. Anal. Bioanal. Chem. 2009, 394, 1171-1182.

   (21)   Damen, C. W.; Israels, T.; Caron, H. N.; Schellens, J. H.; Rosing, H.; Beijnen, J. H. Validated Assay for the Simultaneous Quantification of Total Vincristine and Actinomycin-D Concentrations in Human EDTA Plasma and of Vincristine Concentrations in Human Plasma Ultrafiltrate by High-Performance Liquid Chromatography Coupled With Tandem Mass Spectrometry. Rapid Commun. Mass Spectrom. 2009, 23, 763-774.

   (22)   De Bruin, M. L.; Dorresteijn, L. D.; van't Veer, M. B.; Krol, A. D.; van der Pal, H. J.; Kappelle, A. C.; Boogerd, W.; Aleman, B. M.; van Leeuwen, F. E. Increased Risk of Stroke and Transient Ischemic Attack in 5-Year Survivors of Hodgkin Lymphoma. J. Natl. Cancer Inst. 2009, 101, 928-937.

   (23)   de Castro, S. M.; Songun, I.; Dwars, B. J. An Unexpected Severe Complication After a Negative Laparoscopic Appendectomy.  Can. J. Surg. 2009, 52, E295-E296.

   (24)   de Korte, N.; Dwars, B. J.; van der Werff, J. F. Degloving Injury of an Extremity. Is Primary Closure Obsolete? J. Trauma 2009, 67, E60-E61.

   (25)   de Kruif, M. D.; Limper, M.; Sierhuis, K.; Wagenaar, J. F.; Spek, C. A.; Garlanda, C.; Cotena, A.; Mantovani, A.; Ten Cate, H.; Reitsma, P. H.; van Gorp, E. C. PTX3 Predicts Severe Disease in Febrile Patients at the Emergency Department. J. Infect. 2009.

   (26)   de Kruif, M. D.; Limper, M.; Hansen, H. R.; De Ruiter, J.; Spek, C. A.; Van Gorp, E. C. M.; Ten Berge, I. J.; Rowshani, A. T.; Ten Cate, H.; Meesters, E. W. Effects of a 3-Month Course of Rosuvastatin in Patients With Systemic Lupus Erythematosus. Ann. Rheum. Dis. 2009, 68, 1654.

   (27)   de Smet, A. M.; Kluytmans, J. A.; Cooper, B. S.; Mascini, E. M.; Benus, R. F.; van der Werf, T. S.; van der Hoeven, J. G.; Pickkers, P.; Bogaers-Hofman, D.; van der Meer, N. J.; Bernards, A. T.; Kuijper, E. J.; Joore, J. C.; Leverstein-van Hall, M. A.; Bindels, A. J.; Jansz, A. R.; Wesselink, R. M.; de Jongh, B. M.; Dennesen, P. J.; van Asselt, G. J.; te Velde, L. F.; Frenay, I. H.; Kaasjager, K.; Bosch, F. H.; van Iterson, M.; Thijsen, S. F.; Kluge, G. H.; Pauw, W.; de Vries, J. W.; Kaan, J. A.; Arends, J. P.; Aarts, L. P.; Sturm, P. D.; Harinck, H. I.; Voss, A.; Uijtendaal, E. V.; Blok, H. E.; Thieme Groen, E. S.; Pouw, M. E.; Kalkman, C. J.; Bonten, M. J. Decontamination of the Digestive Tract and Oropharynx in ICU Patients. N. Engl. J. Med. 2009, 360, 20-31.

   (28)   de Vries, N. A.; Beijnen, J. H.; van Tellingen, O. High-Grade Glioma Mouse Models and Their Applicability for Preclinical Testing. Cancer Treat. Rev. 2009, 35, 714-723.

   (29)   den Hertog, H. M.; van der Worp, H. B.; van Gemert, H. M.; Algra, A.; Kappelle, L. J.; van Gijn, J.; Koudstaal, P. J.; Dippel, D. W. The Paracetamol (Acetaminophen) In Stroke (PAIS) Trial: a Multicentre, Randomised, Placebo-Controlled, Phase III Trial. Lancet Neurol. 2009, 8, 434-440.

   (30)   den Hertog, H. M.; van Rossum, J. A.; van der Worp, H. B.; van Gemert, H. M.; de Jonge, R.; Koudstaal, P. J.; Dippel, D. W. C-Reactive Protein in the Very Early Phase of Acute Ischemic Stroke: Association With Poor Outcome and Death. J. Neurol. 2009.

   (31)   Dentali, F.; Rancan, E.; van Zaane, B.; Gerdes, V. E.; Venco, A.; Ageno, W.; Squizzato, A. The Effect of Thyroid Autoantibodies on Warfarin Stability. Thromb. Res. 2009.

   (32)   Desar, I. M. E.; Burger, D. M.; van Hoesel, Q. G. C. M.; Beijnen, J. H.; van Herpen, C. M. L.; van der Graaf, W. T. A. Pharmacokinetics of Sunitinib in an Obese Patient With a GIST. Ann. Oncol. 2009, 20, 599-600.

   (33)   Doets, H. C.; Vergouw, D.; Veeger, H. E.; Houdijk, H. Metabolic Cost and Mechanical Work for the Step-to-Step Transition in Walking After Successful Total Ankle Arthroplasty. Hum. Mov Sci. 2009, 28, 786-797.

   (34)   Douma, R. A.; Gibson, N. S.; Gerdes, V. E.; Buller, H. R.; Wells, P. S.; Perrier, A.; Le Gal, G. Validity and Clinical Utility of the Simplified Wells Rule for Assessing Clinical Probability for the Exclusion of Pulmonary Embolism. Thromb. Haemost. 2009, 101, 197-200.

   (35)   Dubbink, H. J.; Taal, W.; van Marion, R.; Kros, J. M.; van, H., I; Bromberg, J. E.; Zonnenberg, B. A.; Zonnenberg, C. B.; Postma, T. J.; Gijtenbeek, J. M.; Boogerd, W.; Groenendijk, F. H.; Smitt, P. A.; Dinjens, W. N.; van den Bent, M. J. IDH1 Mutations in Low-Grade Astrocytomas Predict Survival but Not Response to Temozolomide. Neurology 2009, 73, 1792-1795.

   (36)   Ekhart, C.; Doodeman, V. D.; Rodenhuis, S.; Smits, P. H.; Beijnen, J. H.; Huitema, A. D. Polymorphisms of Drug-Metabolizing Enzymes (GST, CYP2B6 and CYP3A) Affect the Pharmacokinetics of Thiotepa and Tepa. Br. J. Clin. Pharmacol. 2009, 67, 50-60.

   (37)   Ekhart, C.; Rodenhuis, S.; Beijnen, J. H.; Huitema, A. D. Carbamazepine Induces Bioactivation of Cyclophosphamide and Thiotepa. Cancer Chemother. Pharmacol. 2009, 63, 543-547.

   (38)   Ekhart, C.; Kerst, J. M.; Rodenhuis, S.; Beijnen, J. H.; Huitema, A. D. Altered Cyclophosphamide and Thiotepa Pharmacokinetics in a Patient With Moderate Renal Insufficiency. Cancer Chemother. Pharmacol. 2009, 63, 375-379.

   (39)   Ekhart, C.; Rodenhuis, S.; Beijnen, J. H.; Huitema, A. D. Pharmacokinetics of Cyclophosphamide and Thiotepa in a Conventional Fractionated High-Dose Regimen Compared With a Novel Simplified Unfractionated Regimen. Ther. Drug Monit. 2009, 31, 95-103.

   (40)   Ekhart, C.; Rodenhuis, S.; Schellens, J. H.; Beijnen, J. H.; Huitema, A. D. Carboplatin Dosing in Overweight and Obese Patients With Normal Renal Function, Does Weight Matter? Cancer Chemother. Pharmacol. 2009, 64, 115-122.

   (41)   Ekhart, C.; Rodenhuis, S.; Smits, P. H.; Beijnen, J. H.; Huitema, A. D. An Overview of the Relations Between Polymorphisms in Drug Metabolising Enzymes and Drug Transporters and Survival After Cancer Drug Treatment. Cancer Treat. Rev. 2009, 35, 18-31.

   (42)   Engwegen, J. Y. M. N.; Mehra, N.; Haanen, J. B. A. G.; Schellens, J. H. M.; Voest, E. E.; Beijnen, J. H. Identification of Two New Serum Protein Profiles for Renal Cell Carcinoma. Oncol. Rep. 2009, 22, 401-408.

   (43)   Frakking, F. N. J.; Brouwer, N.; van de Wetering, M. D.; Budde, I. K.; Strengers, P. F. W.; Huitema, A. D.; Laursen, I.; Houen, G.; Caron, H. N.; Dolman, K. M.; Kuijpers, T. W. Safety and Pharmacokinetics of Plasma-Derived Mannose-Binding Lectin (MBL) Substitution in Children With Chemotherapy-Induced Neutropaenia. Eur. J. Cancer 2009, 45, 505-512.

   (44)   Gasem, M. H.; Wagenaar, J. F. P.; Goris, M. G. A.; Adi, M. S.; Isbandrio, B. B.; Hartskeerl, R. A.; Rolain, J. M.; Raoult, D.; Van Gorp, E. C. M. Murine Typhus and Leptospirosis As Causes of Acute Undifferentiated Fever, Indonesia. Emerg. Infect. Dis. 2009, 15, 975-977.

   (45)   Gast, M. C.; van Dulken, E. J.; van Loenen, T. K.; Kingma-Vegter, F.; Westerga, J.; Flohil, C. C.; Knol, J. C.; Jimenez, C. R.; van Gils, C. H.; Wessels, L. F.; Schellens, J. H.; Beijnen, J. H. Detection of Breast Cancer by Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Tissue and Serum Protein Profiling. Int. J. Biol. Markers 2009, 24, 130-141.

   (46)   Gast, M. C.; van Gils, C. H.; Wessels, L. F.; Harris, N.; Bonfrer, J. M.; Rutgers, E. J.; Schellens, J. H.; Beijnen, J. H. Serum Protein Profiling for Diagnosis of Breast Cancer Using SELDI-TOF MS. Oncol. Rep. 2009, 22, 205-213.

   (47)   Gast, M. C.; van Gils, C. H.; Wessels, L. F.; Harris, N.; Bonfrer, J. M.; Rutgers, E. J.; Schellens, J. H.; Beijnen, J. H. Influence of Sample Storage Duration on Serum Protein Profiles Assessed by Surface-Enhanced Laser Desorption/Ionisation Time-of-Flight Mass Spectrometry (SELDI-TOF MS). Clin. Chem. Lab Med. 2009, 47, 694-705.

   (48)   Gast, M. C.; Schellens, J. H.; Beijnen, J. H. Clinical Proteomics in Breast Cancer: a Review. Breast Cancer Res. Treat. 2009, 116, 17-29.

   (49)   Gehring, K.; Sitskoorn, M. M.; Gundy, C. M.; Sikkes, S. A.; Klein, M.; Postma, T. J.; van den Bent, M. J.; Beute, G. N.; Enting, R. H.; Kappelle, A. C.; Boogerd, W.; Veninga, T.; Twijnstra, A.; Boerman, D. H.; Taphoorn, M. J.; Aaronson, N. K. Cognitive Rehabilitation in Patients With Gliomas: a Randomized, Controlled Trial. J. Clin. Oncol. 2009, 27, 3712-3722.

   (50)   Gibson, N. S.; Schellong, S. M.; Kheir, D. Y.; Beyer-Westendorf, J.; Gallus, A. S.; McRae, S.; Schutgens, R. E.; Piovella, F.; Gerdes, V. E.; Buller, H. R. Safety and Sensitivity of Two Ultrasound Strategies in Patients With Clinically Suspected Deep Venous Thrombosis: a Prospective Management Study. J. Thromb. Haemost. 2009, 7, 2035-2041.

   (51)   Gibson, N. S.; Sohne, M.; Gerdes, V. E.; Meijers, J. C.; Buller, H. R. Clinical Usefulness of Prothrombin Fragment 1+2 in Patients With Suspected Pulmonary Embolism. Thromb. Res. 2009.

   (52)   Harmsen, S.; Meijerman, I.; Febus, C. L.; Maas-Bakker, R. F.; Beijnen, J. H.; Schellens, J. H. M. PXR-mediated induction of P-glycoprotein by anticancer drugs in a human colon adenocarcinoma-derived cell line. Cancer Chemotherapy and Pharmacology . 2009.
Ref Type: In Press

   (53)   Harmsen, S.; Meijerman, I.; Beijnen, J. H.; Schellens, J. H. M. Nuclear Receptor Mediated Induction of Cytochrome P450 3A4 by Anticancer Drugs: A Key Role for the Pregnane X Receptor. Cancer Chemother. Pharmacol. 2009, 64, 35-43.

   (54)   Hendrikx, J. J. M. A.; Beijnen, J. H.; Schellens, J. H. M. Methylnaltrexone. Oncologist 2009, 14, 679-682.

   (55)   Hinnen, C.; Sanderman, R.; Sprangers, M. A. Adult Attachment As Mediator Between Recollections of Childhood and Satisfaction With Life. Clin. Psychol. Psychother. 2009, 16, 10-21.

   (56)   Hofsted, M.; von Rosenstiel, I. A.; Jong, M.; Meijer, J. The Implementation of Integrative Medicine in the Netherlands : a National Survey Among Hospitals, Psychiatrics, Revalidation- and Academic Centres. Eur. J. Integrative Med. 2009, 1, 220-221.

   (57)   Jansen, R. S.; Rosing, H.; Schellens, J. H.; Beijnen, J. H. Simultaneous Quantification of 2',2'-Difluorodeoxycytidine and 2',2'-Difluorodeoxyuridine Nucleosides and Nucleotides in White Blood Cells Using Porous Graphitic Carbon Chromatography Coupled With Tandem Mass Spectrometry. Rapid Commun. Mass Spectrom. 2009, 23, 3040-3050.

   (58)   Jansen, R. S.; Rosing, H.; Schellens, J. H.; Beijnen, J. H. Protein Versus DNA As a Marker for Peripheral Blood Mononuclear Cell Counting. Anal. Bioanal. Chem. 2009, 395, 863-867.

   (59)   Jansen, R. S.; Rosing, H.; Schellens, J. H.; Beijnen, J. H. Retention Studies of 2'-2'-Difluorodeoxycytidine and 2'-2'-Difluorodeoxyuridine Nucleosides and Nucleotides on Porous Graphitic Carbon: Development of a Liquid Chromatography-Tandem Mass Spectrometry Method. J. Chromatogr. A 2009, 1216, 3168-3174.

   (60)   Janssen, D.; Zwartele, R. E.; Doets, H. C.; Verdonschot, N. Computational Assessment of Press-Fit Acetabular Implant Fixation: the Effect of Implant Design, Interference Fit, Bone Quality, and Frictional Properties. Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine 2010, 224, 67-75.

   (61)   Jong, E.; Louw, S.; Meijers, J. C.; de Kruif, M. D.; Ten Cate, H.; Buller, H. R.; Mulder, J. W.; van Gorp, E. C. The Hemostatic Balance in HIV-Infected Patients With and Without Antiretroviral Therapy: Partial Restoration With Antiretroviral Therapy. AIDS Patient. Care STDS. 2009, 23, 1001-1007.

   (62)   Jong, E.; van Gorp, E. C.; Mulder, J. W.; Tol, A.; Smits, P. H. Effect of HIV Viral Load, CD4 Cell Count and Antiretroviral Therapy on Human Papillomavirus Prevalence in Urine Samples of HIV-Infected Men. Int. J. STD AIDS 2009, 20, 262-264.

   (63)   Kabasakal, Y.; Kitapcioglu, G.; Yargucu, F.; Taylan, A.; Argin, M.; Gumusdis, G. Efficacy of SLZ and MTX (Alone or Combination) on the Treatment of Active Sacroiliitis in Early AS. Rheumatol. Int. 2009, 29, 1523-1527.

   (64)   Kang, H.; Kim, Y. S.; Ko, J. A Novel Isoform of Human LZIP Negatively Regulates the Transactivation of the Glucocorticoid Receptor. Mol. Endocrinol. 2009, 23, 1746-1757.

   (65)   Keizer, R. J.; Zamacona, M. K.; Jansen, M.; Critchley, D.; Wanders, J.; Beijnen, J. H.; Schellens, J. H.; Huitema, A. D. Application of Population Pharmacokinetic Modeling in Early Clinical Development of the Anticancer Agent E7820. Invest New Drugs 2009, 27, 140-152.

   (66)   Kesselring, A. M.; Wit, F. W.; Sabin, C. A.; Lundgren, J. D.; Gill, M. J.; Gatell, J. M.; Rauch, A.; Montaner, J. S.; de Wolf, F.; Reiss, P.; Mocroft, A. Risk Factors for Treatment-Limiting Toxicities in Patients Starting Nevirapine-Containing Antiretroviral Therapy. AIDS 2009, 23, 1689-1699.

   (67)   Kim, Y. S.; Nur, E.; van Beers, E. J.; Truijen, J.; Davis, S. C. A. T.; Biemond, B. J.; van Lieshout, J. J. Dynamic Cerebral Autoregulation in Homozygous Sickle Cell Disease. Stroke 2009, 40, 808-814.

   (68)   Koolen, S. L.; Huitema, A. D.; Jansen, R. S.; van Voorthuizen, T.; Beijnen, J. H.; Smit, W. M.; Schellens, J. H. Pharmacokinetics of Gemcitabine and Metabolites in a Patient With Double-Sided Nephrectomy: a Case Report and Review of the Literature. Oncologist. 2009, 14, 944-948.

   (69)   Lagas, J. S.; Van Waterschoot, R. A. B.; Van Tilburg, V. A. C. J.; Hillebrand, M. J.; Lankheet, N.; Rosing, H.; Beijnen, J. H.; Schinkel, A. H. Brain Accumulation of Dasatinib Is Restricted by P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) and Can Be Enhanced by Elacridar Treatment. Clin. Cancer Res. 2009, 15, 2344-2351.

   (70)   Lagas, J. S.; Van Der Kruijssen, C. M. M.; Van De Wetering, K.; Beijnen, J. H.; Schinkel, A. H. Transport of Diclofenac by Breast Cancer Resistance Protein (ABCG2) and Stimulation of Multidrug Resistance Protein 2 (ABCC2)-Mediated Drug Transport by Diclofenac and Benzbromarone. Drug Metab. Dispos. 2009, 37, 129-136.

   (71)   Landburg, P. P.; Nur, E.; Maria, N.; Brandjes, D. P. M.; Biemond, B. J.; Schnog, J. B.; Duits, A. J. Elevated Circulating Stromal-Derived Factor-1 Levels in Sickle Cell Disease. Acta Haematol. 2009, 122, 64-69.

   (72)   Langdahl, B. L.; Rajzbaum, G.; Jakob, F.; Karras, D.; Ljunggren, +.; Lems, W. F.; Fahrleitner-Pammer, A.; Bernard Walsh, J.; Barker, C.; Kutahov, A.; Marin, F. Reduction in Fracture Rate and Back Pain and Increased Quality of Life in Postmenopausal Women Treated With Teriparatide: 18-Month Data From the European Forsteo Observational Study (EFOS). Calcif. Tissue Int. 2009, 85, 484-493.

   (73)   Lankheet, A. G.; Hillebrand, M. J.; Langenberg, M. H.; Rosing, H.; Huitema, A. D.; Voest, E. E.; Schellens, J. H.; Beijnen, J. H. A Validated Assay for the Quantitative Analysis of Vatalanib in Human EDTA Plasma by Liquid Chromatography Coupled With Electrospray Ionization Tandem Mass Spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2009, 877, 3625-3630.

   (74)   Lawrence, H. P.; Binguis, D.; Douglas, J.; McKeown, L.; Switzer, B.; Figueiredo, R.; Reade, M. Oral Health Inequalities Between Young Aboriginal and Non-Aboriginal Children Living in Ontario, Canada. Community Dent. Oral Epidemiol. 2009, 37, 495-508.

   (75)   Meuleman, W.; Engwegen, J. Y. M. N.; Gast, M. C. W.; Wessels, L. F. A.; Reinders, M. J. T. Analysis of Mass Spectrometry Data Using Sub-Spectra. BMC Bioinform. 2009, 10.

   (76)   Mocroft, A.; Sterne, J. A.; Egger, M.; May, M.; Grabar, S.; Furrer, H.; Sabin, C.; Fatkenheuer, G.; Justice, A.; Reiss, P.; D'Arminio, M. A.; Gill, J.; Hogg, R.; Bonnet, F.; Kitahata, M.; Staszewski, S.; Casabona, J.; Harris, R.; Saag, M. Variable Impact on Mortality of AIDS-Defining Events Diagnosed During Combination Antiretroviral Therapy: Not All AIDS-Defining Conditions Are Created Equal. Clin. Infect. Dis. 2009, 48, 1138-1151.

   (77)   Nur, E.; Kim, Y. S.; Truijen, J.; van Beers, E. J.; Davis, S. C.; Brandjes, D. P.; Biemond, B. J.; van Lieshout, J. J. Cerebrovascular Reserve Capacity Is Impaired in Patients With Sickle Cell Disease. Blood 2009, 114, 3473-3478.

   (78)   Oostendorp, R. L.; Huitema, A.; Rosing, H.; Jansen, R. S.; Heine, R. T.; Keessen, M.; Beijnen, J. H.; Schellens, J. H. M. Coadministration of Ritonavir Strongly Enhances the Apparent Oral Bioavailability of Docetaxel in Patients With Solid Tumors. Clin. Cancer Res. 2009, 15, 4228-4233.

   (79)   Oostendorp, R. L.; Loftiss, J.; Goel, S.; Smith, D. A.; Dar, M. M.; Witteveen, P. O.; Cohen, R. B.; Lewis, L. D.; Kurian, S.; Patnaik, A.; Rosing, H.; Beijnen, J. H.; Voest, E. E.; Burris, H.; Schellens, J. H. M. Bioequivalence Study of a New Oral Topotecan Formulation, Relative to the Current Topotecan Formulation, in Patients With Advanced Solid Tumors. Int. J. Clin. Pharmacol. Ther. 2009, 47, 195-206.

   (80)   Oostendorp, R. L.; Witteveen, P. O.; Schwartz, B.; Vainchtein, L. D.; Schot, M.; Nol, A.; Rosing, H.; Beijnen, J. H.; Voest, E. E.; Schellens, J. H. M. Dose-finding and pharmacokinetic study of orally administered indibulin (D-24851) to patients with advanced solid tumors. Investigational New Drugs . 2009.
Ref Type: In Press

   (81)   Oostendorp, R. L.; Beijnen, J. H.; Schellens, J. H. M. The Biological and Clinical Role of Drug Transporters at the Intestinal Barrier. Cancer Treat. Rev. 2009, 35, 137-147.

   (82)   Oostendorp, R. L.; van de, S. E.; van der Kruijssen, C. M.; Beijnen, J. H.; Kenworthy, K. E.; Schinkel, A. H.; Schellens, J. H. Organic Anion-Transporting Polypeptide 1B1 Mediates Transport of Gimatecan and BNP1350 and Can Be Inhibited by Several Classic ATP-Binding Cassette (ABC) B1 and/or ABCG2 Inhibitors. Drug Metab Dispos. 2009, 37, 917-923.

   (83)   Oostendorp, R. L.; Buckle, T.; Beijnen, J. H.; van Tellingen, O.; Schellens, J. H. The Effect of P-Gp (Mdr1a/1b), BCRP (Bcrp1) and P-Gp/BCRP Inhibitors on the in Vivo Absorption, Distribution, Metabolism and Excretion of Imatinib. Invest New Drugs 2009, 27, 31-40.

   (84)   Papapanagiotou, D.; Nicu, E. A.; Bizzarro, S.; Gerdes, V. E. A.; Meijers, J. C.; Nieuwland, R.; van der Velden, U.; Loos, B. G. Periodontitis Is Associated With Platelet Activation. Atherosclerosis 2009, 202, 605-611.

   (85)   Peter, W. F.; Steultjens, M. P.; Mesman, T.; Dekker, J.; Hoeksma, A. F. Interobserver Reliability of the Amsterdam Severity Scale in Stenosing Tenosynovitis (ASSiST). J. Hand Ther. 2009, 22, 355-359.

   (86)   Peters, K. S.; Doets, H. C. Midterm Results of Cementless Total Hip Replacement in Rapidly Destructive Arthropathy and a Review of the Literature. Hip. Int. 2009, 19, 352-358.

   (87)   Pluim, D.; Beijnen, J. H.; Schellens, J. H. M.; van Tellingen, O. Simultaneous Determination of AZD1152 (Prodrug) and AZD1152-Hydroxyquinazoline Pyrazol Anilide by Reversed Phase Liquid Chromatography. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2009, 877, 3549-3555.

   (88)   Quaak, S. G.; van den Berg, J. H.; Oosterhuis, K.; Beijnen, J. H.; Haanen, J. B.; Nuijen, B. DNA Tattoo Vaccination: Effect on Plasmid Purity and Transfection Efficiency of Different Topoisoforms. J. Control Release 2009, 139, 153-159.

   (89)   Quaak, S. G.; Nuijen, B.; Haanen, J. B.; Beijnen, J. H. Development and Validation of an Anion-Exchange LC-UV Method for the Quantification and Purity Determination of the DNA Plasmid PDERMATT. J. Pharm. Biomed. Anal. 2009, 49, 282-288.

   (90)   Rafi, S.; van Doormaal, F. F.; van Lienden, K. P.; Kamphuisen, P. W.; Gerdes, V. E. A. Venous Thrombo-Embolism and Aortic Calcifications; More Evidence on the Link Between Venous and Arterial Thrombosis. Thromb. Res. 2009, 124, 381-382.

   (91)   Richard, E.; Kuiper, R.; Dijkgraaf, M. G.; Van Gool, W. A. Vascular Care in Patients With Alzheimer's Disease With Cerebrovascular Lesions-a Randomized Clinical Trial. J. Am. Geriatr. Soc. 2009, 57, 797-805.

   (92)   Schellens, J. H.; Beijnen, J. H. Novel Clinical Trial Designs for Innovative Therapies. Clin. Pharmacol. Ther. 2009, 85, 212-216.

   (93)   Schilder, C. M.; Eggens, P. C.; Seynaeve, C.; Linn, S. C.; Boogerd, W.; Gundy, C. M.; Beex, L. V.; van Dam, F. S.; Schagen, S. B. Neuropsychological Functioning in Postmenopausal Breast Cancer Patients Treated With Tamoxifen or Exemestane After AC-Chemotherapy: Cross-Sectional Findings From the Neuropsychological TEAM-Side Study. Acta Oncol. 2009, 48, 76-85.

   (94)   Schilder, C. M.; Seynaeve, C.; Linn, S. C.; Boogerd, W.; Gundy, C. M.; Beex, L. V.; van Dam, F. S.; Schagen, S. B. The Impact of Different Definitions and Reference Groups on the Prevalence of Cognitive Impairment: a Study in Postmenopausal Breast Cancer Patients Before the Start of Adjuvant Systemic Therapy. Psychooncology. 2009.

   (95)   Schilder, C. M.; Seynaeve, C.; Linn, S. C.; Boogerd, W.; Beex, L. V.; Gundy, C. M.; Nortier, J. W.; van de Velde, C. J.; van Dam, F. S.; Schagen, S. B. Cognitive Functioning of Postmenopausal Breast Cancer Patients Before Adjuvant Systemic Therapy, and Its Association With Medical and Psychological Factors. Crit Rev. Oncol. Hematol.  2009.

   (96)   Schilt, T.; Koeter, M. W.; de Win, M. M.; Zinkstok, J. R.; van Amelsvoort, T. A.; Schmand, B.; den Brink, W. V. The Effect of Ecstasy on Memory Is Moderated by a Functional Polymorphism in the Cathechol-O-Methyltransferase (COMT) Gene. Eur. Neuropsychopharmacol. 2009, 19, 116-124.

   (97)   Shapiro, W. R.; Johanson, C. E.; Boogerd, W. Treatment Modalities for Leptomeningeal Metastases. Semin. Oncol. 2009, 36, S46-S54.

   (98)   Songun, I.; van de Velde, C. J. How Does Extended Lymphadenectomy Influence Practical Care for Patients With Gastric Cancer? Nat. Clin. Pract. Oncol. 2009, 6, 66-67.

   (99)   Sparidans, R. W.; Iusuf, D.; Schinkel, A. H.; Schellens, J. H. M.; Beijnen, J. H. Liquid Chromatography-Tandem Mass Spectrometric Assay for the Light Sensitive Tyrosine Kinase Inhibitor Axitinib in Human Plasma. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2009, 877, 4090-4096.

(100)   Sparidans, R. W.; Vlaming, M. L.; Lagas, J. S.; Schinkel, A. H.; Schellens, J. H.; Beijnen, J. H. Liquid Chromatography-Tandem Mass Spectrometric Assay for Sorafenib and Sorafenib-Glucuronide in Mouse Plasma and Liver Homogenate and Identification of the Glucuronide Metabolite. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2009, 877, 269-276.

(101)   Squizzato, A.; Manfredi, E.; van Zaane, B.; Gerdes, V. E. Is Catheter-Related Thrombosis After Cardiac Surgery Clinically Relevant? Intern. Emerg. Med. 2009, 4, 267-268.

(102)   Squizzato, A.; Micieli, E.; Galli, M.; Gibson, N.; Gerdes, V. E.; Dentali, F.; Buller, H.; Ageno, W.; Venco, A. Diagnosis and Management of Venous Thromboembolism: Results of a Survey on Current Clinical Practice. Thromb. Res. 2009.

(103)   Stolarczyk, P.; Haverkamp, D.; Pöll, R. Infection after total knee arthroplasty : is rheumatoid arthroplasty really a risk factor.  2009. 8-10-0009.
Ref Type: Conference Proceeding

(104)   Stolarczyk, P.; Haverkamp, D.; Pöll, R. Does early mobilisation under anaesthesia for limited flexion after TKP improve the final outcome.  2009. 8-10-0009.
Ref Type: Conference Proceeding

(105)   Strijbos, M. H.; Landburg, P. P.; Nur, E.; Teerlink, T.; Leebeek, F. W. G.; Rijneveld, A. W.; Biemond, B. J.; Sleijfer, S.; Gratama, J. W.; Duits, A. J.; Schnog, J. J. B. Circulating Endothelial Cells: A Potential Parameter of Organ Damage in Sickle Cell Anemia? Blood Cells Mol. Dis. 2009, 43, 63-67.

(106)   Suharti, C.; van Gorp, E. C.; Dolmans, W. M.; Groen, J.; Hadisaputro, S.; Djokomoeljanto, R. J.; Dme, O. A.; van der Meer, J. W. Expression of NF-KB and COX-2 in Young Versus Older Patients With Sporadic Colorectal Cancer. Acta Med. Indones. 2009, 41, 75-80.

(107)   Ter Heine, R.; Davids, M.; Rosing, H.; van Gorp, E. C.; Mulder, J. W.; van der Heide, Y. T.; Beijnen, J. H.; Huitema, A. D. Quantification of HIV Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors in Peripheral Blood Mononuclear Cell Lysate Using Liquid Chromatography Coupled With Tandem Mass Spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2009, 877, 575-580.

(108)   Ter Heine, R.; Hillebrand, M. J.; Rosing, H.; van Gorp, E. C.; Mulder, J. W.; Beijnen, J. H.; Huitema, A. D. Quantification of the HIV-Integrase Inhibitor Raltegravir and Detection of Its Main Metabolite in Human Plasma, Dried Blood Spots and Peripheral Blood Mononuclear Cell Lysate by Means of High-Performance Liquid Chromatography Tandem Mass Spectrometry. J. Pharm. Biomed. Anal. 2009, 49, 451-458.

(109)   Ter Heine, R.; Rosing, H.; van Gorp, E. C.; Mulder, J. W.; Beijnen, J. H.; Huitema, A. D. Quantification of Etravirine (TMC125) in Plasma, Dried Blood Spots and Peripheral Blood Mononuclear Cell Lysate by Liquid Chromatography Tandem Mass Spectrometry. J. Pharm. Biomed. Anal. 2009, 49, 393-400.

(110)   Ter Heine, R.; Hillebrand, M. J.; Rosing, H.; van Gorp, E. C.; Mulder, J. W.; Beijnen, J. H.; Huitema, A. D. Identification and Profiling of Circulating Metabolites of Atazanavir, a HIV Protease Inhibitor. Drug Metab Dispos. 2009, 37, 1826-1840.

(111)   Ter Heine, R.; Huitema, A. D.; Jansen, R. S.; Smits, P. H.; van Gorp, E. C.; Wagenaar, J. F.; Beijnen, J. H.; Mulder, J. W. Prolonged Exposure to Tenofovir Monotherapy 1 Month After Treatment Discontinuation Because of Tenofovir-Related Renal Failure. Antivir. Ther. 2009, 14, 299-301.

(112)   Terhaar Sive Droste, J. S.; Craanen, M. E.; van der Hulst, R. W. M.; Bartelsman, J. F.; Bezemer, D. P.; Cappendijk, K. R.; Meijer, G. A.; Morsink, U. M.; Snel, P.; Tuynman, H. A. R. E.; Van Wanrooy, R. L. J.; Wesdorp, E. I. C.; Mulder, C. J. J. Colonoscopic Yield of Colorectal Neoplasia in Daily Clinical Pratice. World J. Gastroenterol. 2009, 15, 1085-1092.

(113)   Teunissen, S. F.; Rosing, H.; Koornstra, R. H.; Linn, S. C.; Schellens, J. H.; Schinkel, A. H.; Beijnen, J. H. Development and Validation of a Quantitative Assay for the Analysis of Tamoxifen With Its Four Main Metabolites and the Flavonoids Daidzein, Genistein and Glycitein in Human Serum Using Liquid Chromatography Coupled With Tandem Mass Spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2009, 877, 2519-2529.

(114)   Tran, L.; Beijnen, J. H.; Huitema, A. D. The Preparation of Radiolabeled Monoclonal Antibodies for Human Use. Hum. Antibodies 2009, 18, 145-156.

(115)   Tran, L.; Baars, J. W.; Maessen, H. J.; Hoefnagel, C. A.; Beijnen, J. H.; Huitema, A. D. R. A Simple and Safe Method for 131I Radiolabeling of Rituximab for Myeloablative High-Dose Radioimmunotherapy. Cancer Biother. Radiopharm. 2009, 24, 103-110.

(116)   Tulner, L. R.; Frankfort, S. V.; Wesselius, F.; van Campen, J. P.; Koks, C. H.; Beijnen, J. H. Do Geriatric Outpatients Adhere to Medication Changes Advised After Assessment? An Exploratory Pilot Study. Curr. Clin. Pharmacol. 2009, 4, 154-158.

(117)   Tulner, L. R.; Kuper, I. M.; van Campen, J. P.; Koks, C. H.; Mac Gillavry, M. R.; Beijnen, J. H.; Brandjes, D. P. Treatment of Hypertension in an Elderly Outpatient Population in the Netherlands. Am. J. Geriatr. Pharmacother. 2009, 7, 204-209.

(118)   Tulner, L. R.; Kuper, I. M.; Frankfort, S. V.; van Campen, J. P.; Koks, C. H.; Brandjes, D. P.; Beijnen, J. H. Discrepancies in Reported Drug Use in Geriatric Outpatients: Relevance to Adverse Events and Drug-Drug Interactions. Am. J. Geriatr. Pharmacother. 2009, 7, 93-104.

(119)   Tulner, L. R.; Jagt-Willlems, H. C.; Beijnen, J. H. Intoxication With Trazodone Caused by Dirty Facsimile Machine. J. Am. Geriatr. Soc. 2009, 57, 1718-1719.

(120)   Ursum, J.; Horsten, N.; Hoeksma, A. F.; van Schaardenburg, D.; Dekker, J.; Roorda, L. Predictors of stenosing tenosynovitis in the hand and hand-related activity limitations in patients with rheumatoid arthritis.  354. 2009. 10-6-0009.
Ref Type: Conference Proceeding

(121)   Vainchtein, L. D.; Rosing, H.; Mirejovsky, D.; Huynh, V.; Lenaz, L.; Schellens, H. M.; Beijnen, J. Simultaneous Quantitative Analysis of EO9 (Apaziquone) and Its Conversion Products EO5a and EO9-Cl in Human and Dog Urine by High-Performance Liqued Chromatography Coupled With Electrospray Tandem Mass Spectrometry. The Open Chem Biochem Meth J 2009, 2, 1-12.

(122)   van Beem, R. T.; Nur, E.; Zwaginga, J. J.; Landburg, P. P.; van Beers, E. J.; Duits, A. J.; Brandjes, D. P.; Lommerse, I.; de Boer, H. C.; van der Schoot, C. E.; Schnog, J. J. B.; Biemond, B. J. Elevated Endothelial Progenitor Cells During Painful Sickle Cell Crisis. Exp. Hematol. 2009, 37, 1054-1059.

(123)   van Beers, E. J.; Schaap, M. C. L.; Berckmans, R. J.; Nieuwland, R.; Sturk, A.; van Doormaal, F. F.; Meijers, J. C. M.; Biemond, B. J. Circulating Erythrocyte-Derived Microparticles Are Associated With Coagulation Activation in Sickle Cell Disease. Haematologica 2009, 94, 1513-1519.

(124)   Van den Berg-Vos RM; Visser, J.; Kalmijn, S.; Fischer, K.; de Visser, M.; de, J., V; de Haan, R. J.; Franssen, H.; Wokke, J. H.; Van den Berg, L. H. A Long-Term Prospective Study of the Natural Course of Sporadic Adult-Onset Lower Motor Neuron Syndromes. Arch. Neurol.  2009, 66, 751-757.

(125)   van den Berg, C. H.; Ruys, T. A.; Nanlohy, N. M.; Geerlings, S. E.; Van Der Meer, J. T.; Mulder, J. W.; Lange, J. A.; Van Baarle, D. Comprehensive Longitudinal Analysis of Hepatitis C Virus (HCV)-Specific T Cell Responses During Acute HCV Infection in the Presence of Existing HIV-1 Infection. J. Viral Hepat. 2009, 16, 239-248.

(126)   van den Berg, J. H.; Oosterhuis, K.; Hennink, W. E.; Storm, G.; van der Aa, L. J.; Engbersen, J. F.; Haanen, J. B.; Beijnen, J. H.; Schumacher, T. N.; Nuijen, B. Shielding the Cationic Charge of Nanoparticle-Formulated Dermal DNA Vaccines Is Essential for Antigen Expression and Immunogenicity. J. Control Release 2009.

(127)   van den Berg, J. H.; Quaak, S. G.; Beijnen, J. H.; Hennink, W. E.; Storm, G.; Schumacher, T. N.; Haanen, J. B.; Nuijen, B. Lipopolysaccharide Contamination in Intradermal DNA Vaccination: Toxic Impurity or Adjuvant? Int. J. Pharm. 2009.

(128)   van den Berg, J. H.; Nujien, B.; Beijnen, J. H.; Vincent, A.; van Tinteren, H.; Kluge, J.; Woerdeman, L. A.; Hennink, W. E.; Storm, G.; Schumacher, T. N.; Haanen, J. B. Optimization of Intradermal Vaccination by DNA Tattooing in Human Skin. Hum. Gene Ther. 2009, 20, 181-189.

(129)   Van Den Broek, F. J. C.; De Graaf, E. J. R.; Dijkgraaf, M. G. W.; Reitsma, J. B.; Haringsma, J.; Timmer, R.; Weusten, B. L. A. M.; Gerhards, M. F.; Consten, E. C. J.; Schwartz, M. P.; Boom, M. J.; Derksen, E. J.; Bijnen, A. B.; Davids, P. H. P.; Hoff, C.; Van Dullemen, H. M.; Heine, G. D. N.; Van Der Linde, K.; Jansen, J. M.; Mallant-Hent, R. C. H.; Breumelhof, R.; Geldof, H.; Hardwick, J. C. H.; Doornebosch, P. G.; Depla, A. C. T. M.; Ernst, M. F.; Van Munster, I. P.; De Hingh, I. H. J. T.; Schoon, E. J.; Bemelman, W. A.; Fockens, P.; Dekker, E. Transanal Endoscopic Microsurgery Versus Endoscopic Mucosal Resection for Large Rectal Adenomas (TREND-Study). BMC Surg. 2009, 9.

(130)   van der Sande, J. J.; van Tinteren, H.; Brandsma, D.; Jobsis, G. J.; Boogerd, W. Brain Metastases in Patients With Pelvic or Abdominal Malignancy Do Not Prevail in the Posterior Fossa: a Retrospective Study. J. Neurol. 2009,  256, 1485-1487.

(131)   van Es, J.; Wagenaar, J. F.; Smits, P. H.; Depla, A. C.; van Gorp, E. C.; Mulder, J. W. Recurrent Increase of Liver Enzymes in a Human Immunodeficiency Virus Infected Male With Recent Acute Hepatitis B Infection. J. Clin. Virol. 2009, 44, vi.

(132)   Van Kan, H. J. M.; de Jonge, E.; Lie-A-Huen, L.; Beijnen, J. Viral Encephalitis Masking Acyclovir Neurotoxicity? A Case Report. Neth. J. Crit. Care 2009, 13, 96-98.

(133)   Van Schaik, S. M.; Kwa, V. I. H.; Van Der Kooi, A. J. Acquired Rippling Muscle Disease Associated With Mild Myasthenia Gravis: A Case Report. J. Neurol. 2009, 256, 1187-1188.

(134)   van Tits, L. J.; van Heerde, W. L.; Landburg, P. P.; Boderie, M. J.; Muskiet, F. A. J.; Jacobs, N.; Duits, A. J.; Schnog, J. B. Plasma Annexin A5 and Microparticle Phosphatidylserine Levels Are Elevated in Sickle Cell Disease and Increase Further During Painful Crisis. Biochem. Biophys. Res. Commun. 2009, 390, 161-164.

(135)   van Vliet, M.; von Rosenstiel, I. A.; Schindhelm, R. K.; Brandjes, D. P.; Beijnen, J. H.; Diamant, M. Ethnic Differences in Cardiometabolic Risk Profile in an Overweight/Obese Paediatric Cohort in the Netherlands: a Cross-Sectional Study. Cardiovasc. Diabetol. 2009, 8, 2.

(136)   van Vliet, M.; von Rosenstiel, I. A.; Schindhelm, R. K.; Brandjes, D. P.; Beijnen, J. H.; Diamant, M. The Association of Elevated Alanine Aminotransferase and the Metabolic Syndrome in an Overweight and Obese Pediatric Population of Multi-Ethnic Origin. Eur. J. Pediatr. 2009, 168, 585-591.

(137)   van Vliet, M.; Von Rosenstiell, I. A.; Schindhelm, R. K.; Brandjes, D. P. M.; Beijnen, J. H.; Diamant, M. Identifying the Metabolic Syndrome in Obese Children and Adolescents: Do Age and Definition Matter? Curr. Clin. Pharmacol. 2009, 4, 233-238.

(138)   van Waterschoot, R. A.; Eman, R. M.; Wagenaar, E.; van der Kruijssen, C. M.; Rosing, H.; Beijnen, J. H.; Schinkel, A. H. ABCC2, ABCC3, and ABCB1, but Not CYP3A, Protect Against Trabectedin-Mediated Hepatotoxicity. Clin. Cancer Res. 2009, 15, 7616-7623.

(139)   Van Waterschoot, R. A. B.; Lagas, J. S.; Wagenaar, E.; Van Der Kruijssen, C. M. M.; Van Herwaarden, A. E.; Song, J. Y.; Rooswinkel, R. W.; van Tellingen, O.; Rosing, H.; Beijnen, J. H.; Schinkel, A. H. Absence of Both Cytochrome P450 3A and P-Glycoprotein Dramatically Increases Docetaxel Oral Bioavailability and Risk of Intestinal Toxicity. Cancer Res. 2009, 69, 8996-9002.

(140)   Van Waterschoot, R. A. B.; Rooswinkel, R. W.; Sparidans, R. W.; Van Herwaarden, A. E.; Beijnen, J. H.; Schinkel, A. H. Inhibition and Stimulation of Intestinal and Hepatic CYP3A Activity: Studies in Humanized CYP3A4 Transgenic Mice Using Triazolam. Drug Metab. Dispos.  2009, 37, 2305-2313.

(141)   Van Winden, A. W.; Gast, M. C. W.; Beijnen, J. H.; Rutgers, E. J.; Grobbee, D. E.; Peeters, P. H.; van Gils, C. H. Validation of Previously Identified Serum Biomarkers for Breast Cancer With SELDI-TOF MS: A Case Control Study. BMC Med. Genomics 2009, 2.

(142)   van Wissen, M.; Gerdes, V. E.; van Gorp, E. C.; Brandjes, D. P.; Soesan, M. Unusual Presentation of Lemierre's Syndrome: Two Cases and a Review. Blood Coagul. Fibrinolysis 2009, 20, 466-469.

(143)   van Zaane, B.; Nur, E.; Squizzato, A.; Dekkers, O. M.; Twickler, M. T.; Fliers, E.; Gerdes, V. E.; Buller, H. R.; Brandjes, D. P. Hypercoagulable State in Cushing's Syndrome: a Systematic Review. J. Clin. Endocrinol. Metab 2009, 94, 2743-2750.

(144)   van Zaane, B.; Reuwer, A. Q.; Büller, H. R.; Kastelein, J. J.; Gerdes, V. E.; Twickler, M. T. Hormones and Cardiovascular Disease: a Shift in Paradigm With Clinical Consequences? Semin. Thromb. Hemost. 2009, 35, 478-487.

(145)   Verkleij, C. J.; Nieuwdorp, M.; Gerdes, V. E.; Morgelin, M.; Meijers, J. C.; Marx, P. F. The Effects of Hyperglycaemia on Thrombin-Activatable Fibrinolysis Inhibitor. Thromb. Haemost. 2009, 102, 460-468.

(146)   Vermaat, J. S.; van, d. T., I; Mehra, N.; Sleijfer, S.; Haanen, J. B.; Roodhart, J. M.; Engwegen, J. Y.; Korse, C. M.; Langenberg, M. H.; Kruit, W.; Groenewegen, G.; Giles, R. H.; Schellens, J. H.; Beijnen, J. H.; Voest, E. E. Two-Protein Signature of Novel Serological Markers Apolipoprotein-A2 and Serum Amyloid Alpha Predicts Prognosis in Patients With Metastatic Renal Cell Cancer and Improves the Currently Used Prognostic Survival Models. Ann. Oncol. 2009.

(147)   von Rosenstiel, I. A. The Children's Clinic for Integrative Medicine in Amsterdam. Eur. J. Integrative Med. 2009, 1, 170.

(148)   Vrieling, A.; Voskuil, D. W.; Bosma, A.; Majoor, D. M.; van Doorn, J.; Cats, A.; Depla, A. C. T. M.; Timmer, R.; Witteman, B. J. M.; Wesseling, J.; Kampman, E.; Van't Veer, L. J. Expression of Insulin-Like Growth Factor System Components in Colorectal Tissue and Its Relation With Serum IGF Levels. Growth Horm. IGF Res. 2009, 19, 126-135.

(149)   Wagenaar, J. F.; Goris, M. G.; Partiningrum, D. L.; Isbandrio, B.; Hartskeerl, R. A.; Brandjes, D. P.; Meijers, J. C.; Gasem, M. H.; van Gorp, E. C. Coagulation Disorders in Patients With Severe Leptospirosis Are Associated With Severe Bleeding and Mortality. Trop. Med. Int. Health 2009.

(150)   Wagenaar, J. F.; Gasem, M. H.; Goris, M. G.; Leeflang, M.; Hartskeerl, R. A.; van der, P. T.; van, '., V; van Gorp, E. C. Soluble ST2 Levels Are Associated With Bleeding in Patients With Severe Leptospirosis. PLoS. Negl. Trop. Dis. 2009, 3, e453.

(151)   Wagenaar, J. F.; Goris, M. G.; Gasem, M. H.; Isbandrio, B.; Moalli, F.; Mantovani, A.; Boer, K. R.; Hartskeerl, R. A.; Garlanda, C.; van Gorp, E. C. Long Pentraxin PTX3 Is Associated With Mortality and Disease Severity in Severe Leptospirosis. J. Infect. 2009, 58, 425-432.

(152)   Zaane, B. V.; Reuwer, A. Q.; Büller, H. R.; Kastelein, J. J. P.; Gerdes, V. E. A.; Twickler, M. T. B. Hormones and Cardiovascular Disease: A Shift in Paradigm With Clinical Consequences? Semin. Thromb. Hemost. 2009, 35, 478-487.

(153)   Zandvliet, A. S.; Schellens, J. H.; Copalu, W.; Beijnen, J. H.; Huitema, A. D. Covariate-Based Dose Individualization of the Cytotoxic Drug Indisulam to Reduce the Risk of Severe Myelosuppression. J. Pharmacokinet. Pharmacodyn. 2009, 36, 39-62.